骨粘連蛋白(ON)重組蛋白
Recombinant Osteonectin (ON)
SPARC; BM-40; Secreted Protein,Acidic,Cysteine-Rich; Basement-membrane protein 40; Secreted protein acidic and rich in cysteine
- 編號(hào)RPA791Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位細(xì)胞膜, 分泌, 細(xì)胞外基質(zhì)
- 預(yù)測(cè)分子量36.4kDa
- 實(shí)際分子量48&28kDa(差異分析請(qǐng)參閱說明書)
- 片段與標(biāo)簽Ala18~Ile303 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 80%
- 等電點(diǎn)5.0
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請(qǐng)參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 744 ¥ 1860 ¥ 3720 ¥ 11160 ¥ 27900
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-0.2 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APA791Hu01 | 骨粘連蛋白(ON)活性蛋白 | Cell?culture;?Activity?Assays. |
EPA791Hu61 | 骨粘連蛋白(ON)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA791Hu61 | 骨粘連蛋白(ON)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA791Hu01 | 骨粘連蛋白(ON)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
CPA791Hu21 | 骨粘連蛋白(ON)卵白蛋白偶聯(lián)物 | Immunogen; SDS-PAGE; WB. |
PAA791Hu01 | 骨粘連蛋白(ON)多克隆抗體 | WB; IHC; ICC; IP. |
PAA791Hu08 | 骨粘連蛋白(ON)多克隆抗體 | WB; IHC; ICC; IP. |
LAA791Hu81 | 骨粘連蛋白(ON)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
LAA791Hu71 | 骨粘連蛋白(ON)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAA791Hu22 | 骨粘連蛋白(ON)單克隆抗體 | WB; IHC; ICC; IP. |
SEA791Hu | 骨粘連蛋白(ON)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA791Hu | 骨粘連蛋白(ON)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSA791Hu01 | 骨粘連蛋白(ON)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
J Mol Med (Berl) | Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance [PubMed: 26199111] |
Muscle Nerve | Effect of resistance ladder training on SPARC expression in skeletal muscle of hindlimb immobilized rats [PubMed: 26467437] |
Medicine (Baltimore) | An Attempt to Evaluate Selected Aspects of “Bone–Fat Axis” Function in Healthy Individuals and Patients With Pancreatic Cancer [PubMed: 26266370] |
British Journal of Cancer | A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma [Pubmed:26889976] |
Journal of diabetes and its complications | Associations between FGF21, osteonectin and bone turnover markers in type 2 diabetic patients with albuminuria. [pubmed:27916484] |
American journal of the medical sciences | Association of Bone Metabolic Markers With Diabetic Retinopathy and Diabetic Macular Edema in Elderly Chinese Individuals With Type 2 Diabetes Mellitus [pubmed:29078839] |
Translational Research in Oral Oncology | Testican 1 (SPOCK1) and protein tyrosine phosphatase, receptor type S (PTPRS) show significant increase in saliva of tobacco users with oral cancer [Doi: 10.1177/2057178X18800534] |
[ENGINEERING OF BIOMATERIALS | Osteoconductive potential of PLGA/bioglass composite biomaterials [] |
留言咨詢